Cargando…
Metabolic syndrome and the incidence of hepatocellular carcinoma: a meta-analysis of cohort studies
BACKGROUND: Patients with metabolic syndrome (MetS) were suggested to have a higher risk of hepatocellular carcinoma (HCC), although the results of previous cohort studies are not consistent. AIM: To perform an updated meta-analysis to evaluate the association between MetS and subsequent incidence o...
Autores principales: | Chen, Yongxin, Li, Xiaofei, Wu, Shuang, Ye, Weiwei, Lou, Lianqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166758/ https://www.ncbi.nlm.nih.gov/pubmed/30310291 http://dx.doi.org/10.2147/OTT.S154848 |
Ejemplares similares
-
Acute glycemic variability and risk of mortality in patients with sepsis: a meta-analysis
por: Li, Xiaofei, et al.
Publicado: (2022) -
Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis
por: Li, Xiaofei, et al.
Publicado: (2020) -
Efficacy and Safety of Adjunctive Recombinant Human Interleukin-2 for Patients with Pulmonary Tuberculosis: A Meta-Analysis
por: Sheng, Lina, et al.
Publicado: (2022) -
Fatal adverse events with molecular targeted agents in the treatment of advanced hepatocellular carcinoma: a meta-analysis of randomized controlled trials
por: Li, Xiaofei, et al.
Publicado: (2018) -
Blockade of CCN4 attenuates CCl(4)-induced liver fibrosis
por: Li, Xiaofei, et al.
Publicado: (2015)